H.R.34 - 21st Century Cures Act 114th Congress (2015-2016) Public Law 114-255 114th Congress (…) SEC. 3024. INFORMED CONSENT WAIVER OR ALTERATION FOR CLINICAL INVESTIGATIONS. (…) (b) Drugs.--Section 505(i)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(i)(4)) is amended by striking ``except where it is not feasible or it is contrary to the best interests of such human beings'' and inserting ``except where it is not feasible, it is contrary to the best interests of such human beings, or the proposed clinical testing poses no more than minimal risk to such human beings and includes appropriate safeguards...